MARKET

ODT

ODT

Odonate Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

28.50
+0.40
+1.42%
After Hours: 28.50 0 0.00% 16:32 10/14 EDT
OPEN
28.10
PREV CLOSE
28.10
HIGH
28.70
LOW
27.64
VOLUME
88.66K
TURNOVER
--
52 WEEK HIGH
43.75
52 WEEK LOW
11.54
MARKET CAP
917.34M
P/E (TTM)
-6.3911
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ODT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ODT News

  • Odonate Therapeutics Enters Oversold Territory
  • Zacks.09/30 16:17
  • Odonate files for $200M shelf stock offering
  • seekingalpha.09/28 01:54
  • 4 of the Best Stocks With Solid Earnings Acceleration
  • Zacks.09/27 13:51
  • 64 Biggest Movers From Yesterday
  • Benzinga.08/28 09:10

More

Industry

Pharmaceuticals
-0.01%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About ODT

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).
More

Webull offers Odonate Therapeutics Inc (ODT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.